0000899243-20-017084.txt : 20200618 0000899243-20-017084.hdr.sgml : 20200618 20200618163218 ACCESSION NUMBER: 0000899243-20-017084 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200617 FILED AS OF DATE: 20200618 DATE AS OF CHANGE: 20200618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCKEE WILLIAM CENTRAL INDEX KEY: 0001237262 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 20972975 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-995-0900 MAIL ADDRESS: STREET 1: 490 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-17 0 0001420565 AILERON THERAPEUTICS INC ALRN 0001237262 MCKEE WILLIAM C/O AILERON THERAPEUTICS, INC. 490 ARSENAL WAY WATERTOWN MA 02472 1 0 0 0 Stock Option (right to buy) 1.15 2020-06-17 4 A 0 12500 0.00 A 2030-06-16 Common Stock 12500 12500 D This option was granted on June 17, 2020. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 17, 2021 or (ii) the date of the Issuer's 2021 Annual Meeting of Stockholders. /s/ Richard Wanstall, attorney-in-fact for William T. McKee 2020-06-18